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Abstract
Background: The prospect of eliminating onchocerciasis from Africa by mass treatment with ivermectin has been
rejuvenated following recent successes in foci in Mali, Nigeria and Senegal. Elimination prospects depend strongly on local
transmission conditions and therefore on pre-control infection levels. Pre-control infection levels in Africa have been
mapped largely by means of nodule palpation of adult males, a relatively crude method for detecting infection. We
investigated how informative pre-control nodule prevalence data are for estimating the pre-control prevalence of
microfilariae (mf) in the skin and discuss implications for assessing elimination prospects.
Methods and Findings: We analyzed published data on pre-control nodule prevalence in males aged $20 years and mf
prevalence in the population aged $5 years from 148 African villages. A meta-analysis was performed by means of Bayesian
hierarchical multivariate logistic regression, accounting for measurement error in mf and nodule prevalence, bioclimatic
zones, and other geographical variation. There was a strong positive correlation between nodule prevalence in adult males
and mf prevalence in the general population. In the forest-savanna mosaic area, the pattern in nodule and mf prevalence
differed significantly from that in the savanna or forest areas.
Significance: We provide a tool to convert pre-control nodule prevalence in adult males to mf prevalence in the general
population, allowing historical data to be interpreted in terms of elimination prospects and disease burden of
onchocerciasis. Furthermore, we identified significant geographical variation in mf prevalence and nodule prevalence
patterns warranting further investigation of geographical differences in transmission patterns of onchocerciasis.
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(OCP). Since 1995, APOC has successfully coordinated mass
treatment with ivermectin in sixteen onchocerciasis-endemic
African countries [1]. Until recently, elimination of onchocerciasis
from African foci was deemed to be not achievable by means of
mass ivermectin treatment alone, considering the large size of the
transmission zones, the mobility of the insect vectors and human

Introduction
In 1995, the World Health Organization launched the African
Programme for Onchocerciasis Control (APOC). At that time,
APOC aimed to control morbidity due to onchocerciasis (river
blindness) in Africa, with a focus on those countries not covered by
the previous Onchocerciasis Control Programme in West Africa
PLOS Neglected Tropical Diseases | www.plosntds.org
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and prevalence of onchocercal morbidity, allowing better estimation of the disease burden of onchocerciasis.
We present a statistical model describing the association
between pre-control nodule prevalence in adult males and precontrol mf prevalence in the general population. Quantitative
relationships for this association have been previously described,
but were based on smaller number of surveys, did not provide
estimates of uncertainty around parameter estimates and model
predictions, and did not account for geographical variation or the
relatively small sample sizes routinely used for the nodule
palpation method, resulting in attenuation bias (due to measurement error in nodule prevalence) [14,15,16,17]. In this study, we
analyzed original pre-control data, accounting for these factors,
and using Bayesian statistical methods, well known for providing
robust uncertainty estimates around model parameters.

Author Summary
Until recently, elimination of onchocerciasis (river blindness) from Africa by mass treatment with ivermectin alone
was deemed impossible. However, recent reports of
elimination of onchocerciasis from various African foci
have stimulated renewed interest. An important determinant of achieving elimination is the pre-control microfilarial (mf) prevalence, i.e. the percentage of people with larval
stages of the Onchocerca volvulus worm in the skin, which
can be detected in a skin snip (a small skin biopsy).
Because this method is considered invasive, pre-control
infection levels in Africa have been mapped mostly by
means of palpation of subcutaneous nodules (protuberances under the skin where the adult worms live) in adult
males, a relatively crude but non-invasive method of
detecting infection. We developed a tool to derive
estimates of pre-control mf prevalence from available
pre-control nodule prevalence estimates. This tool can
help evaluate ongoing control programs, help assess local
elimination prospects, and help estimate levels of disease
due to onchocerciasis by linking pre-control nodule
palpation data to the large body of literature on the
association between mf prevalence and disease.

Methods
Data and Study Sites
We analyzed original data on pre-control nodule prevalence in
adult males (N = 7,525 individuals) and mf prevalence in the
population aged five years and above (N = 29,775 individuals)
from 148 villages in seven geographical areas including countries
in the former OCP area, and foci in Cameroon, Nigeria, and
Uganda, which are part of APOC (Table 1, Figure 1). Most of
these data have been previously published [9,14,18,19], except for
part of the data from Cameroon. The simuliid vectors responsible
for transmission in each area have been described previously
(Table 1) [9,19,20,21,22,23]. In all areas, data on nodule and mf
prevalence had been collected simultaneously (except for Nigeria,
where nodule palpation took place six to twelve months after skin
snipping, though still before the start of control interventions). All
data on mf prevalence were based on taking two skin snips (one
from each iliac crest) from each individual examined, which were
incubated in saline for 24 hours, and village-level prevalence
values were age- and sex-standardized according to the reference
OCP population (direct standardization, supplementary Table S1).
Then, we calculated the standardized number of mf positive
persons in a village by multiplying the standardized prevalence
with the sample size, and rounding to the nearest integer. Nodule
prevalence was based on palpation-based detection of nodules that
could be attributed to onchocerciasis with reasonable certainty,
similar to the methodology used for mapping of infection in
APOC areas; i.e. nodules of uncertain etiology (e.g. possible
enlarged lymph nodes) were excluded [12]. All data were used
with permission of the authors who originally collected such data,
and were analyzed anonymously.

populations, and poor compliance with mass treatment in some
areas [2]. However, following the first reports of elimination of
onchocerciasis from foci in Mali, Senegal, and Nigeria by mass
treatment alone [3,4,5], there is renewed interest in elimination of
onchocerciasis from Africa [6].
Pre-control infection levels are an important predictor of
morbidity levels [7,8,9] and the duration of onchocerciasis control
programs required to achieve elimination of infection [10,11].
High pre-control levels of infection indicate circumstances that are
favorable for intense transmission in terms of vector abundance,
proximity to vector breeding sites, high vectorial capacity and
competence, etc. In such circumstances, mass treatment with a
drug such as ivermectin, which is predominantly microfilaricidal,
but has a lesser impact on adult worm survival, needs to be
continued for a long time and at high therapeutic and
geographical coverage before it can be stopped without considerable risk of recrudescence of infection. Progress towards
elimination of onchocerciasis from APOC areas is currently being
evaluated by means of ongoing skin snipping surveys that measure
levels of infection in terms of presence and density of microfilariae
(mf) in the skin of the general population [5]. In contrast, precontrol levels of infection in APOC areas have been quantified by
the REMO method (rapid epidemiological mapping of onchocerciasis), which is based on the palpation of subcutaneous nodules
containing adult Onchocerca volvulus worms in a sample of 30–50
males aged $20 years in villages selected using a standardized
selection procedure [12,13]. Results from pre-control and ongoing
surveys will have to be compared, even though the REMO
method is much cruder for detecting presence and intensity of
infection than skin snipping. Therefore, it is important to assess
how informative pre-control nodule palpation data are, and when
and whether they can be reliably translated to equivalent measures
of skin microfilariae. In other words, there is need for a
quantitative model describing the association between pre-control
nodule prevalence and pre-control presence of skin microfilariae,
which takes into account the differences between the two methods
as well as other covariates. Such a model would also allow
estimates of pre-control nodule prevalence to be related to the
large body of literature on the correlation between mf prevalence
PLOS Neglected Tropical Diseases | www.plosntds.org

Statistical Methods and Model Fitting
The association between village-level mf prevalence and nodule
prevalence was quantified in a meta-analysis by means of
hierarchical multivariate logistic regression, i.e. logistic regression
where the predicted outcome is a set of correlated binary random
variables rather than a single binary random variable. A
hierarchical approach was taken to account for unmeasured
sources of variation between geographical areas. A multivariate
approach was taken to account for measurement error in each
measure of infection. This approach prevents regression of model
coefficients towards zero (attenuation bias) as we do not have to
assume that there is no measurement error in the explanatory
variable (e.g. either nodule or mf prevalence), an assumption
inherent to univariate regression [24].
We extended the ordinary hierarchical logistic regression model
to a multivariate model simultaneously predicting m binary
2
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unpublished

outcomes:

logit pij,m yij,m ~kij,m DXij ,bm ,nij,m ~XTij bm zeij zej ,

1,257

Savanna

S. damnosum s.s. and S. sirbanum [22]

where pij,m is the probability of finding k cases of the m-th binary
outcome (m = 1: presence of microfilariae in the skin; m = 2:
presence of nodules in adult males) among nm observed individuals
from the i-th unit (village) and the j-th cluster (geographical area).
The error terms eij and ej (each consisting of m components)
represent the variation (random effects) in infection levels within
and between the j geographical areas, respectively. For each village
there is a set of observed covariates Xij , and for each of the m
predicted binary outcomes there is a set of parameters bm (fixed
effects), where the intercepts b0,m~1 and b0,m~2 represent the
mean log odds of presence of mf in the general population (all
those aged $5 years) and nodules in adult males. To explain
possible large differences between geographical areas related to
bioclime, parasite strains and clinical manifestations in onchocerciasis [25], we included a set of coefficients for bioclimatic zone in
the model. Here, the parameters b1,m~1 and b1,m~2 represent the
log odds ratio of observing microfilariae in the skin and
subcutaneous nodules in forest areas (including degraded forest
and forest-savanna mosaic areas), relative to savanna areas.
Correlation between nodule and mf prevalence was modeled by
assuming a multivariate normal distribution for the m components
of the error term at each level of analysis. See supplementary Text
S1, section ‘‘Model description’’ for a more detailed description of
the model.
To account for measurement error due to misclassification of
nodules (e.g. classifying lymph nodes as onchocercal nodules due
to imperfect specificity; or failing to detect at least one
subcutaneous onchocercal nodule when one or more are present,
due to imperfect sensitivity), we added parameters to the model for
specificity and sensitivity of nodule palpation, allowing these to be
estimated from the data. Prior information for parameter values
was based on the literature. A wide range of values is reported for
specificity (60%–99%), based on various definitions [15,19,26,27].
We assumed that when performed by physicians experienced in
recognizing onchocercal nodules, specificity of nodule palpation is
between 98% and 100%, based on the report of finding only four
non-onchocercal nodules among 312 extirpated nodules [19].
Further, we assumed that sensitivity increases with level of
infection, reflecting the notion that detection of at least one
nodule is more likely in a person with many onchocercal nodules
than in a person with few or only one [27]. In literature, no values
for sensitivity of nodule palpation as a method for detecting
onchocercal nodules are reported. In the current study, sensitivity
was assumed to increase linearly from some unknown minimum
sensitivity (value between 60% and 100%) for nodule prevalences
close to zero (when persons with nodules have few nodules) to
100% for nodule prevalence of 100%. The choice of a linearly
increasing pattern was based on a simulation exercise in which we
examined the association between the proportion of the nodule
carriers that is detected and the ‘true’ nodule prevalence, given
simulated true nodule counts (assuming a negative binomial
distribution of counts within a village) and some probability to
detect each nodule (minimum sensitivity). A sensitivity analysis
showed that the model fit and model predictions did not change
when assuming different values for minimum sensitivity of nodule
palpation at low infection levels (60%, 80%, or 100%). This is
explained by the fact that sensitivity is most important for high
prevalence settings (for which we assume sensitivity is high
anyway), and far less important in low prevalence settings (where

s.s.: sensu stricto.
doi:10.1371/journal.pntd.0002168.t001
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368

unpublished

[14,18]
S. damnosum s.s. and S. sirbanum [20]

S. squamosum B [23]
Forest-savanna mosaic

Savanna
4,266

6,190

19
Vina, Cameroon

1,122

34
Mbam, Cameroon

1,354

[14,18]

unpublished
S. squamosum B [23]

S. damnosum s.s. and S. sirbanum [21]
Savanna

Degraded forest
3,430

7,274
1,822
33

19

Kaduna, Nigeria

Lekié, Cameroon

806

[19]

[9,14,18]
S. damnosum s.s. and S. sirbanum [9]

S. neavei s.s. [19]
Forest

Savanna
Onchocerciasis Control Programme in West Africa

2,085
8

26

Kigoyera Parish, Uganda

667

1,386

Number of
villages
Area

5,273

Bioclime
Number of individuals
from general population
examined for
microfilariae in the skin
Number of males
examined for
nodules

Table 1. Characteristics of data used for modeling the association between prevalence of nodules and microfilariae.

Vector responsible for
transmission (Simulium spp)

Reference
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Figure 1. Locations of study sites.
doi:10.1371/journal.pntd.0002168.g001

Gibbs sampling algorithm (version 3.2.0; Martyn Plummer, 2012,
http://mcmc-jags.sourceforge.net). Simulations in JAGS were set
up and analyzed in R (version 2.14.2) [28], using packages rjags
(version 3–5, Martyn Plummer, 2011, http://CRAN.R-project.
org/package = rjags) and R2jags (version 0.03-06, Yu-Sung Su,
2011, http://CRAN.R-project.org/package = R2jags). Improvements in model fit by addition of parameters were assessed via the
deviance information criterion (DIC), a generalization of Akaike’s
information criterion for hierarchical models (lower values indicate
better fit, taking into account model deviance and the effective
number of parameters in the model) [29]. See Text S1, section
‘‘Parameter estimation’’ for further details about model fitting and
checking of model convergence.
The final fit of the model to the data was evaluated by means of
mixed posterior predictive checks [30,31]. In this procedure, the
number of individuals positive for mf and nodules in each village
was resampled 40,000 times from the estimated joint posterior
distribution of model parameters, including resampling of all

misclassification is largely governed by specificity). Therefore, we
simplified the final model by leaving out the parameter for
sensitivity, effectively assuming 100% sensitivity of nodule
palpation for all infection levels.
Based on the model described above, we estimated the
conditional distribution of mf prevalence in a hypothetical village
outside the dataset, given an estimate of the ‘true’ nodule
prevalence in adult males (i.e. corrected for misclassification of
nodules). We assumed that nodule prevalence estimates were
based on a sample of 30 adult males, the minimal sample size used
in REMO surveys [12,13]. See Text S1, section ‘‘Model
application’’ for a more detailed description of the methods for
predicting mf prevalences in hypothetical villages.
The model was fitted to the data in a Bayesian framework.
Posterior distributions of parameters and predictions were
simulated in JAGS (see Text S1, section ‘‘Model specification in
JAGS’’ for code), a program for analysis of Bayesian models using
Markov Chain Monte Carlo (MCMC) simulation based on the

PLOS Neglected Tropical Diseases | www.plosntds.org
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Figure 2. Association between prevalence of nodules in adult males and skin mf in the general population. Colored symbols represent
data from seven geographical areas. Colored ellipses indicate the 95% percentiles (Z = 1.96) of the predicted joint distributions of infection
prevalences within each geographical area, based on the estimated variances and correlation of observations within geographical areas. Black
symbols represent the mean infection prevalences in each of the geographical areas. The black ellipse represents the 95% percentile of the joint
distribution of mean infection prevalences in geographical areas, illustrating the deviating pattern in nodule and mf prevalence in Mbam, Cameroon
(black and brown crosshairs and brown ellipse). Predictions were based on a Bayesian hierarchical multivariate logistic regression model with a fixed
effect for Mbam, Cameroon, and random effects for other geographical areas.
doi:10.1371/journal.pntd.0002168.g002

Nodule prevalence in adult males was strongly positively
correlated with mf prevalence in the general population (Table
S2). There was significant geographical variation in patterns of
nodule and mf prevalence; in a model without any coefficients for
bioclime, the DIC increased from 1918 to 1920 when error term ej
was omitted. Point estimates of ej were very similar for savanna
and forest areas, with the exception of Mbam, Cameroon (forestsavanna mosaic), for which mf prevalence was relatively high
compared to other areas. In line with this, the model fit did not
improve when a fixed effect parameter for bioclime was added to
the model. However, the model fit improved significantly when

random effects, and the resulting replicate dataset was compared
to the original data.

Results
The median nodule prevalence in males aged $20 years was
58% (range: 2%–100%), and the median mf prevalence in the
population aged five years and above was 74% (4%–99%). The
median sample size for nodule prevalence in a village was 42
(range: 9–181). The median sample size for mf prevalence in a
village was 167 (33–727).

PLOS Neglected Tropical Diseases | www.plosntds.org
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Figure 3. Predicted skin mf prevalence in the general population, given observed nodule prevalence in adult males. Symbols
represent observed data by geographical area. Within each set of regression lines, the middle and outer lines relate to the median and 95% Bayesian
credible intervals of the posterior predictive distribution, respectively (black set for areas all areas but Mbam; grey set for Mbam, the only forestsavanna mosaic area). Predictions were made assuming that nodule prevalence was based on a sample of 30 adult males.
doi:10.1371/journal.pntd.0002168.g003

modeling the difference between Mbam and all other areas as a
fixed effect (DIC 1913 vs. DIC 1918), indicating that mf
prevalences in Mbam were significantly higher than those in
other areas (Table S2, Figure 2). After this adaptation of the

model, there was still significant variation in patterns of nodule
and mf prevalence between geographical areas due to other,
unmeasured variables (the DIC increased to 1921 when error term
ej was omitted). Further, there was considerable uncertainty in the

Figure 4. Comparison of observations (x-axis) versus model predictions (y-axis). The comparison was made by means of mixed posterior
predictive checks of the numbers of individuals with detectable microfilariae in the skin and adult males with nodules. The dotted diagonal line
represents the hypothetical perfect model fit. Error bars represent the 95% Bayesian prediction interval for the numbers of adult males with nodules
and individuals with detectable microfilariae in the skin each village, and should intersect with the diagonal line if the model fit is good.
doi:10.1371/journal.pntd.0002168.g004
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predictions for mf prevalence, based on nodule prevalence in a
sample of 30 males from a hypothetical village outside the dataset
(Figure 3).
Mixed posterior predictive checks showed that the model fitted
well to the data (Figure 4). Only three villages – all from different
regions, and all with relatively low infection levels compared to
other villages from the same region – deviated significantly from
the model predictions.

by parasite characteristics not related to the classic subdivision into
forest and savanna strains. Herder [35] concluded that the parasite
strains circulating in the Faro and Mbam areas were related but
distinct from the strains from Vina and Lekié, based on
phylogenetic linkage patterns. However, this pattern was not
confirmed by our analysis as the association between nodule and
mf prevalence in Faro was very similar to the other areas but
Mbam.
Our model could be used as a tool for assessing the prospects of
elimination of onchocerciasis or the burden of onchocercal disease
when pre-control nodule prevalence in adult males is the only
measure of infection available (as is the case for most of Africa).
With our model, an estimate of pre-control mf prevalence may be
derived from pre-control nodule prevalence data. Such an
estimate may be helpful for program planning, providing an
indication of minimum program duration (with regard to
prospects of elimination), and could be helpful in the interpretation
of ongoing epidemiological parasitological surveys that rely on the
skin snipping method (in terms of progress towards elimination).
Prospects of elimination may be evaluated by comparing the
model-derived estimate of mf prevalence to known trends of
infection levels in other foci with a similar history of mass
treatment, or by means of dynamic modeling of the effect of mass
treatments with ivermectin using onchocerciasis transmission
models such as ONCHOSIM [10,11,36] and others [37,38,39].
Progress towards elimination could be evaluated by comparing
current mf prevalences with model-derived estimates of precontrol mf prevalence and predicted trends in infection levels
based on dynamical modeling. Likewise, the pre-control burden of
ocular and dermal morbidity in endemic areas may be estimated
based on literature data on the association between mf and disease
prevalence [7,8,9]. This would further allow assessment of the
impact of control activities on population health, especially when
combined with aforementioned dynamic models. If pre-control mf
prevalence were to be severely underestimated or overestimated
when derived from nodule prevalence data (due to measurement
error and geographical variation), this may have important
repercussions for the number of treatment rounds that is thought
to be required to reach elimination, or the estimated burden of
disease. Therefore, it is crucial to consider variation due to sample
size and geographical variation in patterns of nodule and mf
prevalence when doing this kind of assessment. Given the high
level of variation and consequent uncertainty in the association
between nodule and mf prevalence, translations should be made
carefully and critically evaluated. We recommend that translations
of village-level REMO data (based on samples of about 30 adult
males) to mf prevalence are made based on the black lines in
Figure 3 (which include uncertainty due to measurement error and
geographical variation). In case of suspected high exposure of
children to flies’ bites, it may be more appropriate to apply the
part of the model that mimics the observations in Mbam,
Cameroon (grey lines in Figure 3). For areas where infection
prevalence is known to be homogeneously distributed, REMO
samples from multiple villages could be pooled into a more precise
estimate of pre-control nodule prevalence in the area, allowing
more precise prediction of the pre-control mf prevalence. In Text
S1, section ‘‘Model application’’, we explain in more detail how
our model should be applied to convert nodule prevalence to mf
prevalence (e.g. how to make predictions for a group of villages).
In conclusion, we provide a tool to convert nodule prevalence in
adult males to mf prevalence in the general population, which
accounts for uncertainty due to measurement error and geographical variation. This tool allows interpretation of a large
amount of pre-control data on levels of infection in Africa which

Discussion
We investigated the association between pre-control nodule
prevalence in adult males (aged $20 years) and pre-control mf
prevalence in the general population (aged $5 years). Our model
is the first to examine geographical variation due to bioclime and
other unmeasured variables, and to take account of measurement
error in nodule prevalence. Our results show that there is a strong
positive correlation between nodule and mf prevalence, but also
significant variation between geographical regions, which should
be taken into consideration when evaluating the prospects of
elimination and the burden of disease.
Our analysis showed significant geographical variation in
patterns of nodule and mf prevalence, though not related to
bioclimatic zones according to the classic forest vs. savanna
classification of onchocerciasis. In ‘forest’ areas – Lekié, Cameroon
(degraded forest) and Kigoyera parish, Uganda (forest) – the
patterns in nodule and mf prevalences did not differ much from
the pattern in savanna areas. Yet, we found that mf prevalence
levels in the general population were relatively higher in the only
forest-savanna mosaic area (Mbam, Cameroon), while nodule
prevalence in adult males levels were not significantly different.
There are several possible explanations for this pattern. Most
likely, the pattern in Mbam is explained by a different pattern in
age-dependent exposure to black flies’ bites. Both mf and nodule
prevalences in individuals under the age of twenty years were
relatively high in Mbam compared to the other areas in
Cameroon, especially in villages with relatively low nodule
prevalence in adult males (data not shown). This indicates that
individuals in Mbam experience relatively high exposure levels at a
young age. This might be explained by the presence of dense forest
in this region with relatively few narrow open spaces, which is
associated with higher dispersal of flies around the breeding sites
[32]. Therefore, exposure may not be concentrated near the
breeding sites, but may extend over the whole village. Related to
this, exposure may be less concentrated in adults (who frequently
spent time near the breeding sites, forest galleries for fishing, etc.),
but may be more equally distributed over all age groups. However,
dense forest may not be unique for Mbam, and may also be
present in other forest areas in our data set. Therefore, we can
only say that it may be important to consider age-dependent
patterns in exposure to black flies’ bites and their effect on
transmission when translating nodule prevalence data to mf
prevalence. We rule out demography and survey methods, as all
mf prevalences were standardized, the mean age of the sampled
men from Mbam was similar to that of men from the other
Cameroonian areas, methods for skin snipping and mf enumeration were the same as in other Cameroonian areas and, in
addition, even conducted by the same person (MB performed all
skin snipping in Faro, Lekié, and Mbam, and 50% of skin snipping
in Vina valley). Furthermore, it is also unlikely that the forest sites
other than Mbam – Lekié and Kigoyera parish – harbor a savanna
parasite strain (instead of the assumed forest parasite strain) as this
is inconsistent with observed patterns of blindness in these areas
(forest pattern) [33,34]. Lastly, variation might have been caused
PLOS Neglected Tropical Diseases | www.plosntds.org
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the current study, and providing the code that was used to specify
the model in JAGS.
(PDF)

may a) be combined with information on coverage of mass
treatment to assess the feasibility of elimination of onchocerciasis
and b) enable estimation of disease burden. Furthermore, we
identified significant geographical variation in mf prevalence and
nodule prevalence patterns that warrants further investigation of
age-dependent transmission patterns of onchocerciasis.
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23. Traoré-Lamizana M, Somiari S, Mafuyai HB, Vajime CG, Post RJ (2001) Sex
chromosome variation and cytotaxonomy of the onchocerciasis vector Simulium
squamosum in Cameroon and Nigeria. Med Vet Entomol 15: 219–223.
24. Carroll RJ, Ruppert D, Stefanski LA, Crainiceanu CM (2006) Measurement
error in nonlinear models: a modern perspective. London: Chapman and Hall.
25. Zimmerman PA, Dadzie KY, De Sole G, Remme J, Alley ES, et al. (1992)
Onchocerca volvulus DNA probe classification correlates with epidemiologic
patterns of blindness. J Infect Dis 165: 964–968.
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